Analyst Ratings for Salix Pharmaceuticals (SLXP)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/6/2011 | Cantor Fitzgerald » Updated 12/20/2011 |
N/A | New Coverage | Buy (N/A) |
60.00 (N/A) |
43.71 (47.72) |
9.17% | Details |
| 10/6/2011 | ThinkEquity | N/A | New Coverage | Buy (N/A) |
40.00 (N/A) |
30.01 (47.72) |
59.01% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
